Pharma & Bio
Lifestyle
Daehwa and Dongkook Defy Market Slump…G2GBIO Falls More Than 10% [K-Bio Pulse]
Pharmaceutical and biotech stocks moved in different directions based on company-specific developments as South Korean stocks fell across both major markets. Daehwa Pharmaceutical gained more than 10%…
- 2026-10-14 07:11:03
- SONG YOUNG-DOO
Lifestyle
DAE HWA PHARM CO., LTD and DongKook Pharmaceutical Co.,Ltd. Break Through the Bear Market… G2GBIO, Inc. Drops Over 10% [Bio Market Watch]
As the domestic stock market showed a broad-based decline, stock prices in the pharmaceutical and biotech sectors also moved in different directions depending on individual company news. DAE HWA PHARM…
- 2026-10-14 07:11:02
- SONG YOUNG-DOO
Technology
Kim Han-shin, CEO of Precision: “To Supply 130 North American Inspection Units by Year-End; Installation Expansion + Cartridge Sales Up”
“We have completed the delivery of 60 diagnostic devices—part of the initial shipment—to North America and plan to deliver a cumulative total of 130 units by the end of the year.”Kim Han-shin, CEO of …
- 2026-10-14 07:01:03
- NA EUN-KYUNG
Technology
[Exclusive] The 9-Year Battle Over Botulinum Toxin Strains to Reach a Conclusion Next January… Key Issues Include
The outcome of the nine-year-long dispute over botulinum toxin strains between Medy-Tox Inc.(086900)and DAEWOONGPHARMACEUTICAL(069620)will be announced in January of next year.Industry observers expec…
- 2026-10-13 17:26:02
- Kim Seung-kwon
Lifestyle
Lilly Follow-On Contract Falls Through; Plant and Clinical Trial Costs Remain a Reality… Peptron, Inc.’s Funding Dilemma
Peptron, Inc.(087010)Peptron is expected to face pressure to secure funding starting next year after concluding a two-year technology evaluation with Eli Lilly without a follow-up commercialization ag…
- 2026-10-13 07:11:02
- Kim Jinsoo
Technology
Park Sang-eon, Director of ENCell Co., Ltd.’s CDMO: “Japan’s Regenerative Medicine Sector to Take Off Next Year… Expanding Cell and Gene CDMO Operations”
Park Sang-eon, Director of the CDMO Business Division at ENCell Co., Ltd. (right), and Kim Hyung-seop, Deputy Head of the New Drug R&D Division (left), were interviewed by Edaily on the 8th at the “Bi…
- 2026-10-12 11:01:02
- Minji Son
Lifestyle
[Exclusive] Global Pharmaceutical Company Finds Alternative in EnsolBio’s Obesity Treatment... ‘Mechanism of Action Challenge’ Fully Resolved
Ensol Biosciences has discovered the key to solving the “yo-yo effect” in obesity treatments—a problem long considered a major challenge in the global pharmaceutical and biotech industries. Having rec…
- 2026-10-12 10:01:02
- YU JIN-HEE
Technology
Peptron, Inc. Falls After Lilly Deal Falls Through… Hanmi Plummets 10% Despite First Weight-Loss Drug Approval [Bio Roundup]
On the 8th, in the domestic pharmaceutical and biotech market, shares of Peptron, Inc.(087010)fell sharply as hopes for a partnership with global pharmaceutical company Eli Lilly faded, while HanmiPha…
- 2026-10-12 08:02:02
- KIM SUNG-JIN
Technology
Caregen Co.,LTD.’s ‘Oral GLP-1’: Claimed to Reduce Muscle Loss by 37%… But According to Published Data, It Was Slower Than the Placebo
Caregen Co.,LTD.(214370)has been promoting “Korglutide,” a weight-management dietary supplement, as an “oral GLP-1 peptide” and emphasizing that it resulted in an average weight loss of 10.78% in just…
- 2026-10-12 07:06:03
- KIM SAE-MI
Lifestyle
Park Jun-hong, Director of May Morning: “RecensMedical, Inc.’s TargetCool Offers Optimal Synergy with Lasers”
“If energy-based medical devices (EBD) are a powerful engine, precision cooling is like a high-performance brake. It’s similar to how having good brakes allows you to utilize the engine’s power more e…
- 2026-10-11 07:06:02
- Kim Jinsoo
PHARM EDAILY
Shorts